Physician
Shukla, Mayank
Shukla, Mayank was paid $2.43M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoSHUKLA, MAYANK
NEW YORK, NY 10016
NEW YORK, NY 10016
33aNPI1356403042assigned 12/16/2006
33bProvider typeSleep Medicine (Internal Medicine) Physician
28Total paid$2.43M
24GClaims55,963
24DCodes billed23
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Sleep Medicine (Internal Medicine) Physician providers in New York
Rank by total paid#1 of 41
Median peer was paid$15K
This provider vs. median162×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,697 | $541K | |
| 2019 | 14,406 | $506K | |
| 2020 | 10,843 | $390K | |
| 2021 | 5,673 | $263K | |
| 2022 | 4,487 | $255K | |
| 2023 | 4,680 | $270K | |
| 2024incomplete | 3,177 | $204K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 9,572 | 8,326 | $595K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 6,017 | 3,578 | $246K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 10% | 1,224 | 1,192 | $244K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.2% | 2,298 | 2,156 | $224K |
| 94060 | 8.3% | 4,357 | 4,336 | $201K | |
| 94729 | 7.8% | 4,034 | 4,015 | $190K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.6% | 1,447 | 1,432 | $184K |
| 94727 | 5.5% | 4,188 | 4,168 | $133K | |
| 94726 | 3.4% | 1,854 | 1,845 | $83K | |
| 95117 | 3.2% | 7,546 | 4,095 | $77K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.7% | 287 | 284 | $66K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.7% | 2,781 | 2,222 | $66K |
11 more codes
| 95012 | 2.4% | 3,581 | $59K | |
| 94150 | <1% | 5,292 | $20K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 35 | $19K |
| 95027 | <1% | 154 | $9K | |
| 95811 | <1% | 12 | $6K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 668 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 228 | $2K |
| 94375 | <1% | 50 | $102.76 | |
| 3008F | 0% | 298 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.